Records containing: Non-metastatic Castration-resistant Prostate Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-20A Multicenter, Real-world Study Evaluating the Effectiveness of Darolutamide Plus ADT in Patients Progressing to nmCRPC After Bicalutamide Plus ADT Treatment During nmHSPC Stage
-
CLINICAL_TRIALS study record update · 2026-04-14Post-marketing Surveillance Study for Approved Darolutamide Use in Korean Patients
-
CLINICAL_TRIALS study record update · 2026-03-19A Single-arm, Open-label Phase 4 Study of Darolutamide in Addition to Standard Androgen Deprivation Therapy for Participants in India With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)
-
CLINICAL_TRIALS study record update · 2026-03-12PROstate CAncer Real World Evidence Registry: RECURRENT AND METASTATIC PROSTATE CANCER
-
CLINICAL_TRIALS study record update · 2025-06-12Use of Darolutamide, Enzalutamide and Apalutamide for Non-metastatic Castration-Resistant Prostate Cancer (nmCRPC) - EXTension of the DEAR Real-world Study (NCT05362149)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-06-08A Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)
-
CLINICAL_TRIALS study record update · 2024-04-09ARI Treatment Use and Outcomes in Non-metastatic Prostate Cancer (nmPC) Patients in the US
-
CLINICAL_TRIALS study record update · 2024-03-20DEAR: Use of Darolutamide, Enzalutamide and Apalutamide in the Real-world for Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)